We have previously shown that PI3′-kinase/AKT signaling plays a pivotal role in pathogenesis of DLBCL and other cancer cells by activating AKT and it's down stream targets, FOXO-1, GSK-3 and Bad [4], [5], [6]. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.